BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19808545)

  • 1. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Fc region of immunoglobulin suppresses atherosclerosis in apolipoprotein E knockout mice].
    Yuan ZY; Liu Y; Kishimoto C; Shioji K; Yokode M; Liu ZQ
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):489-93. PubMed ID: 12887764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes.
    Tekabe Y; Luma J; Einstein AJ; Sedlar M; Li Q; Schmidt AM; Johnson LL
    J Nucl Med; 2010 Jan; 51(1):92-7. PubMed ID: 20008983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
    Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
    J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury.
    Tekabe Y; Luma J; Li Q; Schmidt AM; Ramasamy R; Johnson LL
    JACC Cardiovasc Imaging; 2012 Jan; 5(1):59-67. PubMed ID: 22239894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
    Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
    Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
    J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
    J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
    Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
    Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
    Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs.
    Johnson LL; Tekabe Y; Kollaros M; Eng G; Bhatia K; Li C; Krueger CG; Shanmuganayagam D; Schmidt AM
    EJNMMI Res; 2014; 4():26. PubMed ID: 25006545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
    Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.
    Torzewski M; Shaw PX; Han KR; Shortal B; Lackner KJ; Witztum JL; Palinski W; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2307-12. PubMed ID: 15528482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage.
    Foteinos G; Afzal AR; Mandal K; Jahangiri M; Xu Q
    Circulation; 2005 Aug; 112(8):1206-13. PubMed ID: 16116071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.
    van Zoelen MA; Schmidt AM; Florquin S; Meijers JC; de Beer R; de Vos AF; Nawroth PP; Bierhaus A; van der Poll T
    J Infect Dis; 2009 Sep; 200(5):765-73. PubMed ID: 19627249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice.
    Bro S; Flyvbjerg A; Binder CJ; Bang CA; Denner L; Olgaard K; Nielsen LB
    Atherosclerosis; 2008 Dec; 201(2):274-80. PubMed ID: 18371970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
    Elgqvist J; Andersson H; Bäck T; Claesson I; Hultborn R; Jensen H; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
    Nucl Med Biol; 2006 Nov; 33(8):1065-72. PubMed ID: 17127181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (
    Varasteh Z; De Rose F; Mohanta S; Li Y; Zhang X; Miritsch B; Scafetta G; Yin C; Sager HB; Glasl S; Gorpas D; Habenicht AJR; Ntziachristos V; Weber WA; Bartolazzi A; Schwaiger M; D'Alessandria C
    Theranostics; 2021; 11(4):1864-1876. PubMed ID: 33408786
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.